Literature DB >> 116400

Manufacture of antithymocyte globulin (ATGAM) for clinical trials.

W J Wechter, J W Nelson, R J Perper, A J Parcells, K W Riebe, J S Evans, P S Satoh, H Ko.   

Abstract

Methods are described for preparing large amounts of horse anti-human thymocyte globulin (ATG, ATGAM; The Upjohn Company) for clinical use. These methods have been used since 1968 to provide material for clinical trials. Characteristics of 40 lots of ATG are summarized.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 116400     DOI: 10.1097/00007890-197910000-00007

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

1.  Differentiation of normal marrow and HL60 cells induced by antithymocyte globulin.

Authors:  R F Hunter; N G Mold; R B Mitchell; A T Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

2.  Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates.

Authors:  J H Stevens; P O'Hanley; J M Shapiro; F G Mihm; P S Satoh; J A Collins; T A Raffin
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.